MARLVEL

GLP 1 Tracker - Within Reach vs its rivals

Side-by-side comparison against GLP 1 Tracker - Within Reach's closest competitors — identity, store metrics, ratings & sentiment, and strategic intel.

GLP 1 Tracker - Within Reach
This App
NimbleRx
Nemesis
Medisafe Carezone: PillMemo
Contender
Blood Sugar Glucose Tracker
Contender
WellView
Contender
Gout Diet - Acid Uric Table
Contender
Hickey’s Pharmacy App
Peer
Dose Medbox
Peer
Luka – Blood Glucose Readings
Peer
GotCGM
Peer
Core Identity
DeveloperCoreBits LLCNimbleRxMarcin Jedrzejak199 Developments Private LimitedWellDyneRxngo phongHickey’s PharmacyDose MedboxPitou Technologies, LLCGluroo Imaginations Inc.
CategoryHealth & FitnessMedicalMedicalMedicalMedicalHealth & FitnessMedicalMedicalMedicalHealth & Fitness
PlatformiOSiOS, AndroidiOSiOSiOS, AndroidiOSiOS, AndroidAndroid, iOSiOSiOS, Android
Store Metrics
Rating4.8 / 54.9 / 54.9 / 54.6 / 52.9 / 54.4 / 50.0 / 54.8 / 54.6 / 53.9 / 5
Ratings Count1298,085121005042040268
PriceFreeFreeFreeFreeFreeFreeFreeFreeFreeFree
Release DateJan 26, 2026Nov 11, 2015Apr 24, 2024Oct 29, 2024Jul 1, 2020Nov 13, 2020Aug 24, 2018Sep 2, 2018May 12, 2024Jan 22, 2026
Last UpdatedFeb 16, 2026Apr 16, 2026Sep 4, 2025May 12, 2026Jun 1, 2026May 8, 2026Apr 14, 2026May 12, 2026Apr 21, 2026Apr 20, 2026
Sentiment & Reviews
Sentimentexcellentpositive--mixed-----
Score90/10075/100--50/100-----
Praises
  • Accountability features like daily check-in reminders help users maintain their health and exercise goals
  • Health data tracking capabilities provide users with a clear view of their personal progress
  • Automated prescription refills and home delivery services provide significant convenience for daily medication management
--
  • Utility of pharmacy locator and cost-saving tools
-----
Complaints-
  • Inconsistent prescription visibility and inaccurate refill availability dates frustrate users attempting to manage medication
--
  • Navigation friction and lack of modern health-tracking features
-----
Requests
  • Expanded health tracking metrics for specific conditions like insulin resistance and dosage management
  • Comprehensive prescription history and vaccination data display requested to improve medication management clarity
--------
Strategic Intel
Strengths
  • Local-first storage architecture creates a privacy-based moat
  • Siri integration lowers logging friction for daily users
  • Apple Health bi-directional sync ensures data portability
  • B2B pharmacy partnership model drives fulfillment volume
  • Integrated delivery service reduces retail friction
  • Encrypted data storage establishes regulatory trust
  • Secure health-sharing mechanism enables caregiver-patient collaboration
  • Inventory management feature reduces medication gaps for chronic users
-
  • Enterprise-grade access to claims data
  • Direct pharmacy benefit management integration
-----
Weaknesses
  • Zero-revenue model limits long-term sustainability
  • Limited tracking metrics for comorbid conditions
  • Small review volume restricts social proof
  • Account authentication failures persist post-update
  • Inconsistent prescription data visibility
  • Lack of HSA payment support
  • Free tier limited to one medication entry
  • No offline-first data synchronization mentioned
-
  • 0.7★ Android-iOS rating gap
  • No wearable integration
  • Outdated UI navigation
-----
Pricingfreefreefreemiumfreemiumfreefreefreefreefreefree
MomentumActiveIntenseZombieIntenseMaintenance-ActiveIntense--
Update Cadence3 versions5 versions1 versions5 versions2 versions, ~4d avg-5 versions5 versions--

Compare GLP 1 Tracker - Within Reach head-to-head

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with editorial review, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by GLP 1 Tracker - Within Reach, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

See methodologyContact support

Data licensed under CC-BY-NC 4.0